Gastrointestinal (GI) NETs

PRRT Trials

• Alpha PRRT with Pb212 (all NET)

• Alpha PRRT with Ac225 (GEPNETs only)

• Lu177 DOTATATE + M3814 (Peposertib)  (GEPNETs)

• Lu177 DOTATATE + Olaparib  (GEPNETs)

• Lu177 DOTATATE + Triapine (GEPNETs)

• Lu177 DOTATATE + Cabozantanib (all NET)

• COMPOSE (GEP NETS)

• NETTER-P: Lutathera in Adolescent Patients 

• NET RETREAT of Lu177 Retreatment vs Everolimus in Midgut NET

Oral Treatment

• CABINET: Cabozantinib in Advanced pNET and Carcinoid Tumors

• CDK4/6 Abemaciclib

SSA Treatments

• Paltusotine in Carcinoid Syndrome 

• SORRENTO: Subcutaneous Octreotide for GEPNETs

Other Trials

• Surviving Long Peptide Vaccine (SurVaxM) in Metastatic NETs